Nautilus Biotechnology
High-throughput, low-cost platform for analyzing and quantifying the human proteome
2
Funding Rounds
$152.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Su*** Pa*** | - | - | - |
| Pa*** Ma***** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Su*** Pa*** | - | - | - |
| Pa*** Ma***** | - | - | |
| Dr* Vi*** S. Pa*** | - | - | |
| Me***** Ep***** | - | - | |
| Ka*** Ak******* | - | - | |
| Ma** Po**** | - | - | |
| Mi***** Al**** | - | - | - |
| Ma** Mc****** | - | - | twitter facebook |
| Fa**** Na*** | - | - |
Funding series
Funding Series Analysis
The company Nautilus Biotechnology has raised a total of $76m in funding over 2 rounds.
Key Insights:
- Nautilus Biotechnology Series B round, May 2020: $76m
- Nautilus Biotechnology Series B round May 2020: $76m
Nautilus Biotechnology Series B round, May 2020
$76m
Nautilus Biotechnology Series B round May 2020
$76m
Industries
Nautilus Biotechnology is active in the following industries:
- Technology
- Biomedical engineering
- Genetics
- Genomics
- Proteomics
- Biology
- Biotechnology
- Engineering